|
|
Volumn 8, Issue 2, 2004, Pages 163-168
|
|
Epidermal growth factor receptor tyrosine kinase inhibitors: evolving role in the treatment of solid tumors.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
GEFITINIB;
MONOCLONAL ANTIBODY;
QUINAZOLINE DERIVATIVE;
DRUG ANTAGONISM;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NEOPLASM;
NURSING;
PHYSIOLOGY;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CARCINOMA, NON-SMALL-CELL LUNG;
ENZYME INHIBITORS;
HUMANS;
LUNG NEOPLASMS;
NEOPLASMS;
QUINAZOLINES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
|
|
EID: 3042743383
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/04.cjon.163-168 Document Type: Review |
|
Times cited : (17)
|
|
References (41)
|
